Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Organigram Global Inc.

Organigram Global Inc. (OGI) Stock Overview

Explore Organigram Global Inc.’s financial performance, market position, analyst ratings, and future outlook.

OGI●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.26
$0.03(2.85%)
U.S. Market is Open · 13:55

Organigram Global Inc. (OGI)

Meyka AI Score

Z

Key Financials

Market Cap181.6M
P/E Ratio-9.89
EPS (TTM)$-0.26
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$1.15
3 Months$0.63
1 Year Target$1.24

OGI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Organigram Global Inc. (NASDAQ: OGI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Organigram Global Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OGI on the NASDAQ shows an RSI of 81.09, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $1.24 for the NASDAQ listing.

Key metrics behind Organigram Global Inc.'s NASDAQ-traded stock include a P/E ratio of -9.89 and a market capitalization of 181.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OGI on the NASDAQ.

Price Performance (NASDAQ: OGI)

1-Day Change
4.88%
5-Day Change
30.91%
1-Month Change
33.47%
3-Month Change
16.22%
6-Month Change
0.78%
Year-to-Date (YTD) Change
-23.21%
1-Year Change
-18.87%
3-Year Change
-5.15%
5-Year Change
-87.97%
All-Time (Max) Change
-95.87%

Contact Information

https://www.organigram.ca
15063841571
145 King Street West, Toronto, ON, M5H 1J8

Company Facts

11,200 Employees
IPO DateMay 21, 2019
CountryCA
Actively Trading

Frequently Asked Questions